Eric Venker's Planned Sale of Roivant Sciences Ltd. Common Shares

Eric Venker, an officer of Roivant Sciences Ltd., has filed a Form 144 to report the planned sale of 118,418 common shares. The shares will be sold pursuant to a Rule 10b5-1 trading plan adopted on March 28, 2025. The sale is expected to occur on October 17, 2025, with an aggregate market value of approximately $2,020,170.82. Venker has also engaged in multiple transactions over the past three months, selling a total of 3,200,000 shares for gross proceeds exceeding $40 million. The shares are held on the NASDAQ exchange, and the sale will be facilitated by Rockefeller Financial LLC.